首页> 外文期刊>Scientific reports. >Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China
【24h】

Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China

机译:中国南部肌营养侧颅骨菌病患者SOD1,FUS和TARDBP基因的筛选

获取原文
       

摘要

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting motor neurons of the brain, brainstem and spinal cord. To date, mutations in more than 30 genes have been linked to the pathogenesis of ALS. Among them, SOD1, FUS and TARDBP are ranked as the three most common genes associated with ALS. However, no mutation analysis has been reported in central-southern China. In this study, we sequenced SOD1, FUS and TARDBP in a central-southern Chinese cohort of 173 patients with ALS (15 familial ALS and 158 sporadic ALS) to detect mutations. As a result, five missense mutations in SOD1, namely, p.D101N, p.D101G, p.C111Y, p.N86S and p.V87A, were identified in three unrelated familial probands and three sporadic cases; two mutations in FUS were found in two unrelated familial probands, including an insertion mutation (p.P525_Y526insY) and a missense mutation (p.R521H); no variants of TARDBP were observed in patients. Therefore, SOD1 mutations were present in 20.0% of familial ALS patients and 1.9% of sporadic ALS patients, while FUS mutations were responsible for 13.3% of familial ALS cases, and TARDBP mutations were rare in either familial or sporadic ALS cases. This study broadens the known mutational spectrum in patients with ALS and further demonstrates the necessity for genetic screening in ALS patients from central-southern China.
机译:肌萎缩侧面硬化症(ALS)是一种影响脑,脑干和脊髓的运动神经元的致命神经变性疾病。迄今为止,超过30个基因的突变与ALS的发病机制有关。其中,SOD1,FUS和TARDBP被排名为与ALS相关的三种最常见的基因。但是,中国中部南部没有突变分析。在这项研究中,我们在南部南方患有173名患者(15家族ALS和158孢子族)患者的南部南部躯体队列中的SOD1,FUS和TARDBP进行测序,以检测突变。结果,在三个无关的家族证据和三种散发病例中鉴定了SOD1中的五种畸形突变,即,P.D101N,P.D101G,P.C111Y,P.N86s和P.V87a;在两个不相关的家族性药物中发现FU的两个突变,包括插入突变(P.P525_Y526)和畸形突变(P.R521H);患者没有观察到TARDBP的变种。因此,SOD1突变以20.0%的家庭ALS患者和1.9%的孢子患者突变,而FUS突变负责13.3%的家族式ALS病例,并且在家族或散发性ALS病例中罕见TARDBP突变。本研究扩大了ALS患者的已知突变谱,进一步证明了中国中部南部患者遗传筛查的必要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号